EFS
REGN icon

Essex Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Essex Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$591K Buy
765
+80
+12% +$61.2K 0.03% 412
2025
Q4 		$529K Buy
685
+109
+19% +$74K 0.03% 425
2025
Q3 		$324K Buy
+576
New +$326K 0.02% 560
2025
Q2 		– Sell
-410
Closed -$260K – 704
2025
Q1 		$260K Buy
410
+78
+23% +$53.6K 0.02% 531
2024
Q4 		$237K Buy
332
+29
+10% +$24.3K 0.02% 553
2024
Q3 		$292K Sell
303
-40
-12% -$44.5K 0.02% 504
2024
Q2 		$382K Buy
343
+83
+32% +$80.5K 0.03% 430
2024
Q1 		$250K Buy
+260
New +$247K 0.02% 456

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Essex Financial Services's REGN Position: Q1 2026 in Review

Essex Financial Services increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q1 2026, buying an estimated $61.2K and bringing the position to 765 shares worth $591K. The position accounts for 0.03% of the portfolio, ranked #412.

Essex Financial Services first reported a position in REGN in Q1 2024 and has held it in 8 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Essex Financial Services held 765 shares of Regeneron Pharmaceuticals worth $591K as of Q1 2026.
  • Essex Financial Services bought 80 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $61.2K.
  • Regeneron Pharmaceuticals made up 0.03% of Essex Financial Services's portfolio in Q1 2026, its #412 holding.
  • Essex Financial Services first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.